<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2021-66-1-31-38</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1335</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Биологическая роль зонулина и эффективность его использования в качестве биомаркера синдрома повышенной кишечной проницаемости</article-title><trans-title-group xml:lang="en"><trans-title>Biological role of zonulin: a biomarker of increased intestinal permeability syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7308-7280</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хавкин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khavkin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хавкин Анатолий Ильич – доктор медицинских наук, профессор, главный научный сотрудник отдела гастроэнтерологии </p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">gastropedclin@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4516-4194</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданова</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanova</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Богданова Наталья Михайловна – кандидат медицинских наук, доцент кафедры пропедевтики детских болезней с курсом общего ухода за детьми</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0992-1709</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Валерия Павловна – доктор медицинских наук, профессор, зав. кафедрой пропедевтики детских болезней с курсом общего ухода за детьми, зав. лабораторией медико-социальных проблем в педиатрии </p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева» ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>29</day><month>03</month><year>2021</year></pub-date><volume>66</volume><issue>1</issue><fpage>31</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1335">https://www.ped-perinatology.ru/jour/article/view/1335</self-uri><abstract><p>Изменение рациона, а также широкий спектр патологических состояний, обусловленных инфекционным агентом, аллергическим или аутоиммунным воспалительным процессом, влияют на биологические ритмы пищеварительного тракта, что оказывает негативное действие на кишечную микробиоту и приводит к повышению проницаемости слизистой оболочки кишечника. Измененная микробиота потенцирует воспаление и способствует возникновению патологического «замкнутого круга». Фактором, модулирующим плотность межклеточных соединений, является белок зонулин. В обзоре представлены данные о биологической роли зонулина, возможностях коррекции при нарушении его синтеза с помощью функциональных продуктов для детского питания.</p></abstract><trans-abstract xml:lang="en"><p>.Both changes in diet and pathological conditions caused by an infectious agent, allergic or autoimmune inflammatory process, affect the biological rhythms of the digestive tract, which negatively affects the intestinal microbiota and increases the permeability of the intestinal mucosa. The altered microbiota potentiates inflammation and causes a “vicious circle”. The zonulin protein is the agent that modulates the density of intercellular connections. The review presents data on the biological role of zonulin, correction of its synthesis violation with the help of functional products for baby food.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>кишечный барьер</kwd><kwd>зонулин</kwd><kwd>проницаемость кишечной стенки</kwd><kwd>биомаркер</kwd><kwd>микробиота</kwd><kwd>метаболизм</kwd><kwd>воспалительные цитокины</kwd><kwd>кисломолочные продукты</kwd><kwd>йогурт</kwd><kwd>обогащенный пребиотиками и пробиотиками</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>intestinal barrier</kwd><kwd>zonulin</kwd><kwd>intestinal wall permeability</kwd><kwd>biomarker</kwd><kwd>microbiota</kwd><kwd>metabolism</kwd><kwd>inflammatory cytokines</kwd><kwd>fermented milk products</kwd><kwd>yoghurt</kwd><kwd>enriched with prebiotics and probiotics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Salvo Romero E., Alonso Cotoner C., Pardo Camacho C., Casado Bedmar M., Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig 2015; 107: 686–696. DOI: 10.17235/reed.2015.3846/2015</mixed-citation><mixed-citation xml:lang="en">Salvo Romero E., Alonso Cotoner C., Pardo Camacho C., Casado Bedmar M., Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig 2015; 107: 686–696. DOI: 10.17235/reed.2015.3846/2015</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Spadoni I., Zagato E., Bertocchi A., Paolinelli R., Hot E., Di Sabatino A. et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science 2015; 350: 830–834. DOI: 10.1126/science.aad0135</mixed-citation><mixed-citation xml:lang="en">Spadoni I., Zagato E., Bertocchi A., Paolinelli R., Hot E., Di Sabatino A. et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science 2015; 350: 830–834. DOI: 10.1126/science.aad0135</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">uigley E.M.M. Leaky gut – concept or clinical entity? Curr Opin Gastroenterol 2016; 32(2): 74–79. DOI: 10.1126/science.aad0135</mixed-citation><mixed-citation xml:lang="en">Uigley E.M.M. Leaky gut – concept or clinical entity? Curr Opin Gastroenterol 2016; 32(2): 74–79. DOI: 10.1126/science.aad0135</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Odenwald M.A., Turner J.R. The intestinal epithelial barrier: A therapeutic target? Nat Rev Gastroenterol Hepatol 2017; 14(1): 9–21. DOI: 10.1038/nrgastro.2016.169</mixed-citation><mixed-citation xml:lang="en">Odenwald M.A., Turner J.R. The intestinal epithelial barrier: A therapeutic target? Nat Rev Gastroenterol Hepatol 2017; 14(1): 9–21. DOI: 10.1038/nrgastro.2016.169</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Talley N.J. Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications. Am J Gastroenterol 2017; 112: 141–144. DOI: 10.1038/ajg.2016.519</mixed-citation><mixed-citation xml:lang="en">Talley N.J. Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications. Am J Gastroenterol 2017; 112: 141–144. DOI: 10.1038/ajg.2016.519</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tran C.D., Grice D.M., Wade B., Kerr C.A., Bauer D.C., Li D., Hannan G.N. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiol 2015; 10: 1339–1353. DOI: 10.2217/FMB.15.54</mixed-citation><mixed-citation xml:lang="en">Tran C.D., Grice D.M., Wade B., Kerr C.A., Bauer D.C., Li D., Hannan G.N. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiol 2015; 10: 1339–1353. DOI: 10.2217/FMB.15.54</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Verwoerd A., Ter Haar N.M., de Roock S., Vastert S.J., Bogaert D. The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016; 14: 55. DOI: 10.1186/s12969-016-0114-4</mixed-citation><mixed-citation xml:lang="en">Verwoerd A., Ter Haar N.M., de Roock S., Vastert S.J., Bogaert D. The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 2016; 14: 55. DOI: 10.1186/s12969-016-0114-4</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hu E.-D., Chen D.-Z., Wu J.-L., Lu F.-B., Chen L., Zheng M.-H. et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cell Immunol 2018; 328: 24–32. DOI: 10.1016/j.aninu.2020.10.001</mixed-citation><mixed-citation xml:lang="en">Hu E.-D., Chen D.-Z., Wu J.-L., Lu F.-B., Chen L., Zheng M.-H. et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cell Immunol 2018; 328: 24–32. DOI: 10.1016/j.aninu.2020.10.001</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bischoff S.C., Barbara G., Buurman W., Ockhuizen T., Schulzke J.-D., Serino M. et al. Intestinal permeability – A new target for disease prevention and therapy. BMC Gastroenterol 2014; 14: 189. DOI: 10.1186/s12876-014-0189-7</mixed-citation><mixed-citation xml:lang="en">Bischoff S.C., Barbara G., Buurman W., Ockhuizen T., Schulzke J.-D., Serino M. et al. Intestinal permeability – A new target for disease prevention and therapy. BMC Gastroenterol 2014; 14: 189. DOI: 10.1186/s12876-014-0189-7</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">oniewska B., W grzyn D., Adamek K., Kaczmarczyk M., Skonieczna-Żydecka K., Adler G. et al. The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study. J Clin Med 2019; 8(4): E47. DOI: 10.3390/jcm8040473</mixed-citation><mixed-citation xml:lang="en">Oniewska B., W grzyn D., Adamek K., Kaczmarczyk M., Skonieczna-Żydecka K., Adler G. et al. The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study. J Clin Med 2019; 8(4): E47. DOI: 10.3390/jcm8040473</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ohlsson B., Orho-Melander M., Nilsson P.M. Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations. Int J Mol Sci 2017; 18(3): E582. DOI: 10.3390/ijms18030582</mixed-citation><mixed-citation xml:lang="en">Ohlsson B., Orho-Melander M., Nilsson P.M. Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations. Int J Mol Sci 2017; 18(3): E582. DOI: 10.3390/ijms18030582</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Krakowiak O., Nowak R. Mikroflora przewodu pokarmowego człowieka–znaczenie, rozwój, modyfikacje. Post Fitoter 2015; 3: 193–200.</mixed-citation><mixed-citation xml:lang="en">Krakowiak O., Nowak R. Mikroflora przewodu pokarmowego człowieka–znaczenie, rozwój, modyfikacje. Post Fitoter 2015; 3: 193–200.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Хавкин А.И., Ипполитов Ю.А., Алешина Е.О., Комарова О.Н. Микробиота и болезни полости рта. Экспериментальная и клиническая гастроэнтерология 2015; 6(118): 78–81.</mixed-citation><mixed-citation xml:lang="en">Khavkin A.Y., Ippolitov Yu.A., Aleshina E.O., Komarova O.N. Microbiota and diseases of the oral cavity. Eksperimental’naya i klinicheskaya gastroenterologiya 2015; 6(118): 78–81. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Хавкин А.И. Микрофлора пищеварительного тракта. М.: Фонд социальной педиатрии, 2006; 416.</mixed-citation><mixed-citation xml:lang="en">Khavkin A.I. The microflora of the digestive tract. Moscow: Fond sotsial’noy pediatrii, 2006; 416. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y.G., Xia Y., Lu R., Sun J. Inflammation and intestinal leakiness in older HIV+ individuals with fish oil treatment. Genes Dis 2018; 5(3): 220–225 DOI: 10.1016/j.gendis.2018.07.001</mixed-citation><mixed-citation xml:lang="en">Zhang Y.G., Xia Y., Lu R., Sun J. Inflammation and intestinal leakiness in older HIV+ individuals with fish oil treatment. Genes Dis 2018; 5(3): 220–225 DOI: 10.1016/j.gendis.2018.07.001</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pastor L., Langhorst J., Schröder D., Casellas A., Ruffer A., Carrillo J. et al. Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection. PLoS One 2019; 14(6): e0218000. DOI: 10.1371/journal.pone.0218000</mixed-citation><mixed-citation xml:lang="en">Pastor L., Langhorst J., Schröder D., Casellas A., Ruffer A., Carrillo J. et al. Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection. PLoS One 2019; 14(6): e0218000. DOI: 10.1371/journal.pone.0218000</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Linsalata M., Riezzo G., D’Attoma B., Clemente C., Orlando A., Russo F. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study. BMC Gastroenterol 2018; 18(1): 167. DOI: 10.1186/s12876-018-0888-6</mixed-citation><mixed-citation xml:lang="en">Linsalata M., Riezzo G., D’Attoma B., Clemente C., Orlando A., Russo F. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study. BMC Gastroenterol 2018; 18(1): 167. DOI: 10.1186/s12876-018-0888-6</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wegh C.A.M., de Roos N.M., Hovenier R., Meijerink J., Besseling-van der Vaart I. et al. Intestinal Permeability Measured by Urinary Sucrose Excretion Correlates with Serum Zonulin and Faecal Calprotectin Concentrations in UC Patients in Remission. J Nutr Metab 2019; 2019: 2472754. DOI: 10.1155/2019/2472754</mixed-citation><mixed-citation xml:lang="en">Wegh C.A.M., de Roos N.M., Hovenier R., Meijerink J., Besseling-van der Vaart I. et al. Intestinal Permeability Measured by Urinary Sucrose Excretion Correlates with Serum Zonulin and Faecal Calprotectin Concentrations in UC Patients in Remission. J Nutr Metab 2019; 2019: 2472754. DOI: 10.1155/2019/2472754</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ling X., Linglong P., Weixia D., Hong W. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPSInduced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model. PLoS ONE 2016; 11: e0161635. DOI: 10.1371/journal.pone.0161635</mixed-citation><mixed-citation xml:lang="en">Ling X., Linglong P., Weixia D., Hong W. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPSInduced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model. PLoS ONE 2016; 11: e0161635. DOI: 10.1371/journal.pone.0161635</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Vojdani A., Vojdani E., Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017; 23: 5669–5679. DOI: 10.3748/wjg.v23.i31.5669</mixed-citation><mixed-citation xml:lang="en">Vojdani A., Vojdani E., Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017; 23: 5669–5679. DOI: 10.3748/wjg.v23.i31.5669</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Scheffler L., Crane A., Heyne H.O., Toenjes A., Schleinitz D., Ihling C.H. et al. Widely used commercial ELISA for human Zonulin reacts with Complement C3 rather than pre-Haptoglobin 2. bioRxiv 2017:157578. DOI: 10.1101/157578</mixed-citation><mixed-citation xml:lang="en">Scheffler L., Crane A., Heyne H.O., Toenjes A., Schleinitz D., Ihling C.H. et al. Widely used commercial ELISA for human Zonulin reacts with Complement C3 rather than pre-Haptoglobin 2. bioRxiv 2017:157578. DOI: 10.1101/157578</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wu M., Wu Y., Deng B., Li J., Cao H., Qu Y., Qian X., Zhong G. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota. Oncotarget 2016; 7: 85318–85331. DOI: 10.18632/oncotarget.13347</mixed-citation><mixed-citation xml:lang="en">Wu M., Wu Y., Deng B., Li J., Cao H., Qu Y., Qian X., Zhong G. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota. Oncotarget 2016; 7: 85318–85331. DOI: 10.18632/oncotarget.13347</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Trachtman H., Gipson D.S., Lemley K.V., Troost J.P., Faul C., Morrison D.J. et al. Plasma Zonulin Levels in Childhood Nephrotic Syndrome. Front Pediatr 2019; 7: 197. DOI: 10.3389/fped.2019.00197</mixed-citation><mixed-citation xml:lang="en">Trachtman H., Gipson D.S., Lemley K.V., Troost J.P., Faul C., Morrison D.J. et al. Plasma Zonulin Levels in Childhood Nephrotic Syndrome. Front Pediatr 2019; 7: 197. DOI: 10.3389/fped.2019.00197</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kim A.S., Ko H.J. Plasma concentrations of zonulin are elevated in obese men with fatty liver disease. Diabetes Metab Syndr Obes 2018; 11: 149–157. DOI: 10.2147/DMSO. S163062</mixed-citation><mixed-citation xml:lang="en">Kim A.S., Ko H.J. Plasma concentrations of zonulin are elevated in obese men with fatty liver disease. Diabetes Metab Syndr Obes 2018; 11: 149–157. DOI: 10.2147/DMSO. S163062</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Stenman L.K., Lehtinen M.J., Meland N., Christensen J.E., Yeung N. et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine 2016; 13: 190–200. DOI: 10.1016/j.ebiom.2016.10.036</mixed-citation><mixed-citation xml:lang="en">Stenman L.K., Lehtinen M.J., Meland N., Christensen J.E., Yeung N. et al. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine 2016; 13: 190–200. DOI: 10.1016/j.ebiom.2016.10.036</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Barengolts E., Green S.J., Chlipala G.E., Layden B.T., Eisenberg Y., Priyadarshini M., Dugas L.R. Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes. Microorganisms 2019; 7(9): E320. DOI: 10.3390/microorganisms7090320</mixed-citation><mixed-citation xml:lang="en">Barengolts E., Green S.J., Chlipala G.E., Layden B.T., Eisenberg Y., Priyadarshini M., Dugas L.R. Predictors of Obesity among Gut Microbiota Biomarkers in African American Men with and without Diabetes. Microorganisms 2019; 7(9): E320. DOI: 10.3390/microorganisms7090320</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Хавкин А.И., Волынец Г.В., Никитин А.В. Взаимосвязь кишечного микробиома и метаболизма желчных кислот. Вопросы практической педиатрии 2020; 15(1): 53–60.</mixed-citation><mixed-citation xml:lang="en">Khavkin A.I., Volynets G.V., Nikitin A.V. The relationship of the gut microbiome and metabolism of bile acids. Voprosy prakticheskoj pediatrii (Clinical Practice in Pediatrics) 2020; 15(1): 53–60. DOI: 10.20953/1817-7646-2020-1-53-60. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Комарова О.Н., Хавкин А.И. Взаимосвязь стресса, иммунитета и кишечной микробиоты. Педиатрическая фармакология 2020; 17(1): 18–24. DOI: 10.15690/pf.v17i1.2078. (in Russ.)</mixed-citation><mixed-citation xml:lang="en">Komarova О.N., Khavkin A.I. Correlation Between Stress, Immunity and Intestinal Microbiota. Pediatricheskaya farmakologiya (Pediatric pharmacology) 2020; 17(1): 18–24. DOI: 10.15690/pf.v17i1.2078. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Pietrukaniec M., Migacz M., Żak-Gołąb A., Olszanecka-Glinianowicz M., Chudek J. et al. Zonulin Family Peptide Levels in Ascites and Serum in Patients with Liver Cirrhosis: A Preliminary Study. Dis Markers 2019; 2019: 2804091. DOI: 10.1155/2019/2804091</mixed-citation><mixed-citation xml:lang="en">Pietrukaniec M., Migacz M., Żak-Gołąb A., Olszanecka-Glinianowicz M., Chudek J. et al. Zonulin Family Peptide Levels in Ascites and Serum in Patients with Liver Cirrhosis: A Preliminary Study. Dis Markers 2019; 2019: 2804091. DOI: 10.1155/2019/2804091</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Guerrant R.L., Leite A.M., Pinkerton R., Medeiros P.H., Cavalcante P.A., DeBoer M. et al. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Northeast Brazil. PLoS One 2016; 11(9): e0158772. DOI: 10.1371/journal.pone.0158772.</mixed-citation><mixed-citation xml:lang="en">Guerrant R.L., Leite A.M., Pinkerton R., Medeiros P.H., Cavalcante P.A., DeBoer M. et al. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Northeast Brazil. PLoS One 2016; 11(9): e0158772. DOI: 10.1371/journal.pone.0158772.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Horvath A., Rainer F., Bashir M., Leber B., Schmerboeck B., Klymiuk I. et al. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep 2019; 9(1) :12000. DOI: 10.1038/s41598-01948352-5</mixed-citation><mixed-citation xml:lang="en">Horvath A., Rainer F., Bashir M., Leber B., Schmerboeck B., Klymiuk I. et al. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep 2019; 9(1) :12000. DOI: 10.1038/s41598-01948352-5</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kasai C., Sugimoto K., Moritani I., Tanaka J., Oya Y., Inoue H. et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol 2015; 15: 100. DOI: 10.1186/s12876-015-0330-2</mixed-citation><mixed-citation xml:lang="en">Kasai C., Sugimoto K., Moritani I., Tanaka J., Oya Y., Inoue H. et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol 2015; 15: 100. DOI: 10.1186/s12876-015-0330-2</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Stanislawski M.A., Dabelea D., Wagner B.D., Sontag M.K., Lozupone C.A., Eggesbø M. Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants. Microbiome 2017; 5: 113. DOI: 10.1186/s40168-017-0332-0</mixed-citation><mixed-citation xml:lang="en">Stanislawski M.A., Dabelea D., Wagner B.D., Sontag M.K., Lozupone C.A., Eggesbø M. Pre-pregnancy weight, gestational weight gain, and the gut microbiota of mothers and their infants. Microbiome 2017; 5: 113. DOI: 10.1186/s40168-017-0332-0</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Egshatyan L., Kashtanova D., Popenko A., Tkacheva O., Tyakht A., Alexeev D. et al. Gut microbiota and diet in patients with different glucose tolerance. Endocr Connect 2016; 5: 1–9. DOI:10.1530/EC-15-0094</mixed-citation><mixed-citation xml:lang="en">Egshatyan L., Kashtanova D., Popenko A., Tkacheva O., Tyakht A., Alexeev D. et al. Gut microbiota and diet in patients with different glucose tolerance. Endocr Connect 2016; 5: 1–9. DOI:10.1530/EC-15-0094</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Crusell M.K.W., Hansen T.H., Nielsen T., Allin K.H., Rühlemann M.C., Damm P. et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 2018; 6: 89. DOI: 10.1186/s40168-018-0472-x</mixed-citation><mixed-citation xml:lang="en">Crusell M.K.W., Hansen T.H., Nielsen T., Allin K.H., Rühlemann M.C., Damm P. et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 2018; 6: 89. DOI: 10.1186/s40168-018-0472-x</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Tang W.H., Wang Z., Kennedy D.J., Wu Y., Buffa J.A., Agatisa-Boyle B. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116: 448–455. DOI: 10.1161/CIRCRESAHA.116.305360</mixed-citation><mixed-citation xml:lang="en">Tang W.H., Wang Z., Kennedy D.J., Wu Y., Buffa J.A., Agatisa-Boyle B. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116: 448–455. DOI: 10.1161/CIRCRESAHA.116.305360</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Tomasova L., Dobrowolski L., Jurkowska H., Wróbel M., Huc T., Ondrias K. et al. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric Oxide 2016; 60: 50–58. DOI: 10.1016/j.niox.2016.09.007</mixed-citation><mixed-citation xml:lang="en">Tomasova L., Dobrowolski L., Jurkowska H., Wróbel M., Huc T., Ondrias K. et al. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric Oxide 2016; 60: 50–58. DOI: 10.1016/j.niox.2016.09.007</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zacarías M.F., Collado M.C., Gómez-Gallego C., Flinck H., Aittoniemi J., Isolauri E. et al. Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester. PLoS ONE 2018; 13: e0200305. DOI: 10.1371/journal. pone.0200305</mixed-citation><mixed-citation xml:lang="en">Zacarías M.F., Collado M.C., Gómez-Gallego C., Flinck H., Aittoniemi J., Isolauri E. et al. Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester. PLoS ONE 2018; 13: e0200305. DOI: 10.1371/journal. pone.0200305</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lv L.-J., Li S.-H., Li S.-C., Zhong Z.-C., Duan H.-L., Tian C. et al. Early-Onset Preeclampsia Is Associated With Gut Microbi Alterations in Antepartum and Postpartum Women. Front Cell Infect Microbiol 2019; 9: 224. DOI: 10.3389/fcimb.2019.00224.</mixed-citation><mixed-citation xml:lang="en">Lv L.-J., Li S.-H., Li S.-C., Zhong Z.-C., Duan H.-L., Tian C. et al. Early-Onset Preeclampsia Is Associated With Gut Microbi Alterations in Antepartum and Postpartum Women. Front Cell Infect Microbiol 2019; 9: 224. DOI: 10.3389/fcimb.2019.00224.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Gomez-Arango L.F., Barrett H.L., McIntyre H.D., Callaway L.K., Morrison M., Dekker Nitert M. et al. Connections between the gut microbiome and metabolic hormones in early pregnancy in overweight and obese women. Diabetes 2016; 65: 2214–2223. DOI: 10.2337/db16-0278</mixed-citation><mixed-citation xml:lang="en">Gomez-Arango L.F., Barrett H.L., McIntyre H.D., Callaway L.K., Morrison M., Dekker Nitert M. et al. Connections between the gut microbiome and metabolic hormones in early pregnancy in overweight and obese women. Diabetes 2016; 65: 2214–2223. DOI: 10.2337/db16-0278</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor B.D., Ness R.B., Olsen J., Hougaard D.M., Skogstrand K., Roberts J.M. et al. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women. Hypertension 2015; 65: 594–599. DOI: 10.1161/HYPERTENSIONAHA.114.03979</mixed-citation><mixed-citation xml:lang="en">Taylor B.D., Ness R.B., Olsen J., Hougaard D.M., Skogstrand K., Roberts J.M. et al. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women. Hypertension 2015; 65: 594–599. DOI: 10.1161/HYPERTENSIONAHA.114.03979</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Natividad J.M., Lamas B., Pham H.P., Michel M.L., Rainteau D., Bridonneau C. et al. Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. Nat Commun 2018; 9: 2802. DOI: 10.1038/s41467-018-05249-7</mixed-citation><mixed-citation xml:lang="en">Natividad J.M., Lamas B., Pham H.P., Michel M.L., Rainteau D., Bridonneau C. et al. Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. Nat Commun 2018; 9: 2802. DOI: 10.1038/s41467-018-05249-7</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015; 16: 448–457. DOI: 10.1038/ni.3153</mixed-citation><mixed-citation xml:lang="en">Hunter C.A., Jones S.A. IL-6 as a keystone cytokine in health and disease. Nat Immunol 2015; 16: 448–457. DOI: 10.1038/ni.3153</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Han Y.W. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol 2015; 23: 141–147. DOI: 10.1016/j.mib.2014.11.013</mixed-citation><mixed-citation xml:lang="en">Han Y.W. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol 2015; 23: 141–147. DOI: 10.1016/j.mib.2014.11.013</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Krautkramer K.A., Kreznar J.H., Romano K.A., Vivas E.I., Barrett-Wilt G.A., Rabaglia M.E. et al. Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 2016;64, 982–992. DOI: 10.1016/j. molcel.2016.10.025</mixed-citation><mixed-citation xml:lang="en">Krautkramer K.A., Kreznar J.H., Romano K.A., Vivas E.I., Barrett-Wilt G.A., Rabaglia M.E. et al. Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 2016;64, 982–992. DOI: 10.1016/j. molcel.2016.10.025</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Schiering C., Wincent E., Metidji A., Iseppon A., Li Y., Potocnik A. J. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 2017; 542: 242–245. DOI: 10.1038/nature21080</mixed-citation><mixed-citation xml:lang="en">Schiering C., Wincent E., Metidji A., Iseppon A., Li Y., Potocnik A. J. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 2017; 542: 242–245. DOI: 10.1038/nature21080</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Yan Q., Gu Y., Li X., Yang W., Jia L., Chen C. et al. Alterations of the gut microbiome in hypertension. Front Cell Infect Microbiol 2017; 7: 381. DOI: 10.3389/fcimb.2017.00381</mixed-citation><mixed-citation xml:lang="en">Yan Q., Gu Y., Li X., Yang W., Jia L., Chen C. et al. Alterations of the gut microbiome in hypertension. Front Cell Infect Microbiol 2017; 7: 381. DOI: 10.3389/fcimb.2017.00381</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Guo X., Li S., Zhang J., Wu F., Li X., Wu D. et al. Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics 2017; 18: 800. DOI: 10.1186/s12864-017-4195-3</mixed-citation><mixed-citation xml:lang="en">Guo X., Li S., Zhang J., Wu F., Li X., Wu D. et al. Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics 2017; 18: 800. DOI: 10.1186/s12864-017-4195-3</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee S.H., Potoulakis C., Maye E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 309–314. DOI: 10.1038/nrgastro.2009.35</mixed-citation><mixed-citation xml:lang="en">Rhee S.H., Potoulakis C., Maye E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 309–314. DOI: 10.1038/nrgastro.2009.35</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens B.R., Goel R., Seungbum K., Richards E.M., Holbert R.C., Pepine C. J., Raizada M.K. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut 2018; 67(8): 1555–1557. DOI: 10.1136/gutjnl-2017-314759</mixed-citation><mixed-citation xml:lang="en">Stevens B.R., Goel R., Seungbum K., Richards E.M., Holbert R.C., Pepine C. J., Raizada M.K. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut 2018; 67(8): 1555–1557. DOI: 10.1136/gutjnl-2017-314759</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce-Keller A.J., Salbaum J.M., Luo M., Blanchard E., Taylor C.M., Welsh D.A., Berthoud H.-R. Reply to: Highfat diet-induced dysbiosis as a cause of neuroinflammation. Biological Psychiatry 2016; 80(1): E5–E6. DOI: 10.1016/j. biopsych.2015.11.006</mixed-citation><mixed-citation xml:lang="en">Bruce-Keller A.J., Salbaum J.M., Luo M., Blanchard E., Taylor C.M., Welsh D.A., Berthoud H.-R. Reply to: Highfat diet-induced dysbiosis as a cause of neuroinflammation. Biological Psychiatry 2016; 80(1): E5–E6. DOI: 10.1016/j. biopsych.2015.11.006</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C., Gao J., Zhang J., Luo A.L. Enterochromaffin cells in the gut: a distant regulator of brain function? Gut 2018; 67(8): 1557–1558. DOI: 10.1155/2019/7902874</mixed-citation><mixed-citation xml:lang="en">Yang C., Gao J., Zhang J., Luo A.L. Enterochromaffin cells in the gut: a distant regulator of brain function? Gut 2018; 67(8): 1557–1558. DOI: 10.1155/2019/7902874</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Ganda Mall J.P., Östlund-Lagerström L., Lindqvist C.M., Algilani S., Rasoal D., Repsilber D. et al. Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? BMC Geriatr 2018; 18(1): 75. DOI: 10.1186/s12877-0180767-6</mixed-citation><mixed-citation xml:lang="en">Ganda Mall J.P., Östlund-Lagerström L., Lindqvist C.M., Algilani S., Rasoal D., Repsilber D. et al. Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? BMC Geriatr 2018; 18(1): 75. DOI: 10.1186/s12877-0180767-6</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Lv W.J., Wu X.L., Chen W.Q., Li Y.F., Zhang G.F., Chao L.M. et al. The Gut Microbiome Modulates the Changes in Liver Metabolism and in Inflammatory Processes in the Brain of Chronic Unpredictable Mild Stress Rats. Oxid Med Cell Longev 2019; 2019: 7902874. DOI: 10.1155/2019/7902874</mixed-citation><mixed-citation xml:lang="en">Lv W.J., Wu X.L., Chen W.Q., Li Y.F., Zhang G.F., Chao L.M. et al. The Gut Microbiome Modulates the Changes in Liver Metabolism and in Inflammatory Processes in the Brain of Chronic Unpredictable Mild Stress Rats. Oxid Med Cell Longev 2019; 2019: 7902874. DOI: 10.1155/2019/7902874</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez-Mon M.A., Gómez A.M., Orozco A., Lahera G., Sosa M.D., Diaz D. et al. Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder. Front Psychiatry 2019; 10: 812. DOI: 10.3389/fpsyt.2019.00812</mixed-citation><mixed-citation xml:lang="en">Alvarez-Mon M.A., Gómez A.M., Orozco A., Lahera G., Sosa M.D., Diaz D. et al. Abnormal Distribution and Function of Circulating Monocytes and Enhanced Bacterial Translocation in Major Depressive Disorder. Front Psychiatry 2019; 10: 812. DOI: 10.3389/fpsyt.2019.00812</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Meinitzer S., Baranyi A., Holasek S., Schnedl W.J., Zelzer S., Mangge H. et al. Sex-Specific Associations of Trimethylamine-N-Oxide and Zonulin with Signs of Depression in Carbohydrate Malabsorbers and Nonmalabsorbers. Dis Markers 2020; 2020: 7897240. DOI: 10.1155/2020/7897240</mixed-citation><mixed-citation xml:lang="en">Meinitzer S., Baranyi A., Holasek S., Schnedl W.J., Zelzer S., Mangge H. et al. Sex-Specific Associations of Trimethylamine-N-Oxide and Zonulin with Signs of Depression in Carbohydrate Malabsorbers and Nonmalabsorbers. Dis Markers 2020; 2020: 7897240. DOI: 10.1155/2020/7897240</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Özyurt G., Öztürk Y., Appak Y.Ç., Arslan F.D., Baran M., Karakoyun . et al. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder. Compr Psychiatry 2018; 87: 138–142. DOI: 10.1016/j.comppsych.2018.10.006.</mixed-citation><mixed-citation xml:lang="en">Özyurt G., Öztürk Y., Appak Y.Ç., Arslan F.D., Baran M., Karakoyun . et al. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder. Compr Psychiatry 2018; 87: 138–142. DOI: 10.1016/j.comppsych.2018.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Kovo M., Schreiber L., Elyashiv O., Ben-Haroush A., Abraham G., Bar J. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia. Reprod Sci 2015; 22: 316–321. DOI: 10.1177/1933719114542024</mixed-citation><mixed-citation xml:lang="en">Kovo M., Schreiber L., Elyashiv O., Ben-Haroush A., Abraham G., Bar J. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia. Reprod Sci 2015; 22: 316–321. DOI: 10.1177/1933719114542024</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Sturgeon C., Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016; 4: e1251384. DOI: 10.1080/21688370.2016.1251384</mixed-citation><mixed-citation xml:lang="en">Sturgeon C., Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016; 4: e1251384. DOI: 10.1080/21688370.2016.1251384</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Tarko A., Suchojad A., Michalec M., Majcherczyk M., Brzozowska A., Maruniak-Chudek I. Zonulin: A Potential Marker of Intestine Injury in Newborns. Dis Markers 2017; 2017: 2413437. DOI: 10.1155/2017/2413437</mixed-citation><mixed-citation xml:lang="en">Tarko A., Suchojad A., Michalec M., Majcherczyk M., Brzozowska A., Maruniak-Chudek I. Zonulin: A Potential Marker of Intestine Injury in Newborns. Dis Markers 2017; 2017: 2413437. DOI: 10.1155/2017/2413437</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Mwape I., Bosomprah S., Mwaba J., Mwila-Kazimbaya K., Laban N.M., Chisenga C.C. et al. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction. PLoS One 2017; 12(12): e0187761. DOI: 10.1155/2017/2413437</mixed-citation><mixed-citation xml:lang="en">Mwape I., Bosomprah S., Mwaba J., Mwila-Kazimbaya K., Laban N.M., Chisenga C.C. et al. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction. PLoS One 2017; 12(12): e0187761. DOI: 10.1155/2017/2413437</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Krawczyk M., Maciejewska D., Ryterska K., CzerwińkaRogowska M., Jamioł-Milc D., Skonieczna-Żydecka K., Milkiewicz P. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction. Nutrients 2018; 10(11): E1793. DOI: 10.3390/nu10111793</mixed-citation><mixed-citation xml:lang="en">Krawczyk M., Maciejewska D., Ryterska K., CzerwińkaRogowska M., Jamioł-Milc D., Skonieczna-Żydecka K., Milkiewicz P. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction. Nutrients 2018; 10(11): E1793. DOI: 10.3390/nu10111793</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Богданова Н.М., Хавкин А.И., Колобова О.Л. Перспективы использования ферментированных молочных продуктов у детей с первичной гиполактазией взрослого типа. Рос вестн перинатол и педиатр 2020; 65(3): 160–168. DOI: 10.21508/1027-4065-2020-65-3-160-168. (in Russ.)</mixed-citation><mixed-citation xml:lang="en">[Bogdanova N.M., Khavkin A.I., Kolobova O.L. Prospects of fermented milk products in children with primary hypolactasia of the adult type. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2020; 65(3): 160–168. DOI: 10.21508/1027-4065-2020-65-3-160-168. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Хавкин А.И., Федотова О.Б., Волынец Г.В., Кошкарова Ю.А., Пенкина Н.А., Комарова О.Н. Результаты проспективного сравнительного открытого рандомизированного исследования по изучению эффективности йогурта, обогащенного пребиотиками и пробиотиками, у детей раннего возраста, перенесших острую респираторную инфекцию. Вопросы детской диетологии 2019; 17(1): 29–37. DOI: 10.20953/1727-5784-2019-1-29-37</mixed-citation><mixed-citation xml:lang="en">Khavkin А.I., Fedotova O.B., Volynets G.V., Koshkarova Yu.A., Penkina N.A., Komarova O.N. The results of a prospective comparative openlabel randomised study of the effectiveness of a probioticand prebiotic-fortified yogurt in small children after an acute respiratory infection. Voprosy detskoi dietologii (Pediatric Nutrition) 2019; 17(1): 29–37. (in Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
